# FDA recall D-0305-2026

> **Granules Pharmaceuticals Inc.** · Class II · drug recall initiated 2026-01-26.

## Product

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

## Reason for recall

Presence of Foreign Tablets/Capsules

## Distribution

US Nationwide.

## Key facts

- **Recall number:** D-0305-2026
- **Recalling firm:** Granules Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-01-26
- **Report date:** 2026-02-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chantilly, VA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0305-2026

## Citation

> AI Analytics. FDA recall D-0305-2026. Retrieved 2026-07-10 from https://api.ai-analytics.org/recall/D-0305-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*